TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vaccination Växjö AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
7,790
|
7,729
|
5,214 |
| Financial expenses |
11
|
22
|
3 |
| Earnings before taxes |
1,559
|
1,445
|
788 |
| EBITDA |
1,560
|
1,466
|
791 |
| Total assets |
5,694
|
4,786
|
3,367 |
| Current assets |
1,641
|
1,361
|
542 |
| Current liabilities |
606
|
716
|
237 |
| Equity capital |
4,699
|
3,734
|
2,853 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
82.5%
|
78.0%
|
84.7% |
| Turnover per employee |
7,790
|
7,729
|
5,214 |
| Profit as a percentage of turnover |
20.0%
|
18.7%
|
15.1% |
| Return on assets (ROA) |
27.6%
|
30.7%
|
23.5% |
| Current ratio |
270.8%
|
190.1%
|
228.7% |
| Return on equity (ROE) |
33.2%
|
38.7%
|
27.6% |
| Change turnover |
61
|
2,515
|
568 |
| Change turnover % |
1%
|
48%
|
12% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.